Provention Bio Inc. (PRVB)
NASDAQ: PRVB
· Real-Time Price · USD
24.98
0.00 (0.00%)
At close: Apr 26, 2023, 10:00 PM
Provention Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 12.89M | 2.8M | 2.72M | 1.98M | 1.4M | 678K | n/a | n/a |
Cost of Revenue | 512K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 12.38M | 2.8M | 2.72M | 1.98M | 1.4M | 678K | n/a | n/a |
Operating Income | -128.16M | -113.82M | -111.82M | -112.16M | -115.55M | -122.34M | -126.67M | -119.29M |
Interest Income | 2.24M | 935K | 290K | 175K | 146K | 158K | 208K | 328K |
Pretax Income | -126.96M | -113.17M | -111.56M | -112.02M | -115.43M | -122.18M | -126.46M | -118.96M |
Net Income | -112.97M | -105.53M | -104.36M | -103.96M | -114.43M | -121.18M | -125.46M | -118.44M |
Selling & General & Admin | 64.11M | 51.13M | 47.67M | 46.87M | 47.35M | 48.06M | 47.77M | 42.33M |
Research & Development | 75.8M | 65.52M | 66.9M | 67.3M | 69.63M | 74.96M | 78.89M | 76.96M |
Other Expenses | 627K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 140.54M | 116.65M | 114.57M | 114.17M | 116.97M | 123.02M | 126.67M | 119.29M |
Interest Expense | 1.18M | 401K | 146K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 141.06M | 116.65M | 114.57M | 114.17M | 116.97M | 123.02M | 126.67M | 119.29M |
Income Tax Expense | -13.98M | -7.62M | -7.12M | -7.97M | -885K | -917K | -972K | -495K |
Shares Outstanding (Basic) | 74.72M | 83.12M | 64.72M | 63.4M | 63.38M | 63.38M | 63.38M | 62.26M |
Shares Outstanding (Diluted) | 74.72M | 83.12M | 64.72M | 63.4M | 63.38M | 63.38M | 63.38M | 62.26M |
EPS (Basic) | -1.6 | -1.56 | -1.65 | -1.65 | -1.82 | -1.99 | -2.12 | -2.11 |
EPS (Diluted) | -1.6 | -1.56 | -1.65 | -1.65 | -1.82 | -1.99 | -2.12 | -2.11 |
EBITDA | -124.89M | -112.57M | -111.41M | -111.89M | -115.41M | -122.29M | -126.52M | -118.99M |
EBIT | -125.83M | -112.83M | -111.53M | -112.16M | -115.55M | -122.34M | -126.67M | -119.29M |
Depreciation & Amortization | 3.27M | 1.25M | 506K | 451K | 387K | 294K | 303K | 373K |